Share :

Download PDF :

Euractiv (14 August 2020)

The European Union said Thursday (13 August) it had reserved up to 400 million doses of a potential new coronavirus vaccine being developed by US giant Johnson & Johnson.

Preliminary talks concluded Friday for a first purchase of 200 million doses followed by an equal number later, a statement said.

“The envisaged contract with Johnson & Johnson would provide for the possibility for all EU Member States to purchase the vaccine, as well as to donate to lower and middle income countries,” it said.

Click for more